During the past decade, The Vascular Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Vascular Group" are "Abdominal Aortic Aneurysm" (1 trials) and "Abdominal Aortic Aneurysms (AAA)" (1 trials). Many other conditions were trialed in "The Vascular Group" in a lesser frequency.

Most popular intervention types in "The Vascular Group" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "AFX EVAR AAA Graft System" (1 trials), "Aptus Endovascular AAA Repair System" (1 trials) and "FDA Approved EVAR AAA Graft Systems" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Vascular Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Vascular Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Vascular Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Vascular Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".